When it comes to 3D printing, the sky is the limit. As 3D printing technology continues to advance, applications can be as far reaching as airplane and automobile parts to medical devices and even anatomically correct, biocompatible models. Although 3D printing technology is developing at a rapid pace, the technology itself is not new. It emerged in the 1980s as a means of creating rapid prototypes. In recent years the applications for 3D printed models have evolved with the available hardware, software, and printable materials. Evolving technology, paired with the creative and innovative minds of scientists, engineers, and physicians, has been the launching pad for developments within 3D printing technology specific to healthcare. One way 3D printing technology is poised to create better patient outcomes is in creating an anatomically and patient-specific models to aid in surgery and medical procedures. With the capability to 3D ...
PolyDADMAC - Superfloc C-500 series- Thanks to Kemira
Polydiallyldimethylammonium chloride (PolyDADMAC) is a homopolymer of diallyldimethylammonium chloride (DADMAC), well known as one part of our Superfloc C-500 series. These organic coagulants are liquid, cationic polymers of differing molecular weights. They work effectively as primary coagulants and charge neutralization agents.
PolyDADMAC is often used in filtration applications or in conjunction with our flocculant products. These polymers are highly effective in many water treatment clarification processes. PolyDADMAC and/or cationic polyamines can also be used in combination with our flocculant and coagulant products to lower overall treatment costs.
PolyDADMAC is often used in filtration applications or in conjunction with our flocculant products. These polymers are highly effective in many water treatment clarification processes. PolyDADMAC and/or cationic polyamines can also be used in combination with our flocculant and coagulant products to lower overall treatment costs.
| ||
watch video:https://www.youtube.com/watch?v=TKAHZECfXok
|
Comments
Post a Comment